Skip to main content
. Author manuscript; available in PMC: 2009 Mar 15.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2008 Mar 15;70(4):1002–1010. doi: 10.1016/j.ijrobp.2007.08.020

Table I.

Gender, age, tumor pathology, anatomical location of the tumor and the total biologically corrected dose (α/β = 2.5) of the 25 patients studied.

Patient # Age Gender Tumor
Pathology
Anatomical
Location of
Tumor
Total
Tumor
Dose
(Gy)
Concurrent
RT +
Temozolomide
1 39 M GBM Left Temporal 72 Yes
2 33 M Diffuse Gemistocytic
Astrocytoma
Right Temporal 70 No
3 62 M GBM Right Fronto-
Temporal
75 Yes
4 40 M GBM Right Occipito-
Parietal
81 Yes
5 31 F GBM Left Temporal 72 Yes
6 64 M GBM Right Temporal 78 Yes
7 66 M GBM Right Parietal 70 No
8 54 F GBM Right Parietal 70 No
9 60 M GBM Right Parietal 75 Yes
10 55 M Secretory
Meningioma
Left Medial
Sphenoid
54 No
11 68 F GBM Left Frontal 60 No
12 70 M GBM Right Frontal 60 No
13 29 M Craniopharyngioma Suprasellar 56 No
14 66 M GBM Right Posterior
Temporal
75 Yes
15 23 F Gliosarcoma Right Temporal 66 Yes
16 71 M Null cell pituitary
Adenoma
Suprasellar 50 No
17 30 M Oligoastrocytoma Left Fronto-
Parietal
58 No
18 73 M GBM Right Temporal 75 Yes
19 56 F GBM Right Frontal 81 Yes
20 44 M GBM Right Fronto-
Parietal
78 Yes
21 62 F GBM Right Parietal 75 Yes
22 73 F GBM Left Occipit-
Parietal
75 Yes
23 69 M GBM Right Temporal 81 Yes
24 75 F GBM Right Parietal 75 Yes
25 39 M Mixed
Oligoastrocytoma
Right Fronto-
Temporal
60 No